BI
HLVX

BVF Inc’s HilleVax HLVX Stock Holding History

BVF Inc’s Portfolio HLVX Stock Details HLVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-248,579
Closed -$4.11M – 70
2023
Q1 		$4.11M Hold
248,579
– – 0.15% 61
2022
Q4 		$4.16M Sell
248,579
-133,873
-35% -$2.42M 0.18% 61
2022
Q3 		$6.54M Sell
382,452
-61
-0% -$887 0.27% 56
2022
Q2 		$4.18M Buy
+382,513
New +$4.54M 0.2% 59

Other funds holding HLVX

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

BVF Inc's HLVX Position: Q2 2023 in Review

BVF Inc sold out of HilleVax (HLVX) in Q2 2023, closing a stake of 248,579 shares — an estimated $4.11M sold.

BVF Inc first reported a position in HLVX in Q2 2022 and held it in 4 quarters. The position peaked at $6.54M in Q3 2022. 54 funds tracked by Wall St. Rank hold HLVX as of Q2 2023.

  • BVF Inc reported no remaining HilleVax position as of Q2 2023 after selling out during the quarter.
  • BVF Inc sold 248,579 HilleVax shares in Q2 2023, an estimated $4.11M.
  • BVF Inc first reported a position in HilleVax in Q2 2022 and held it in 4 quarters.
  • BVF Inc's HilleVax position peaked at $6.54M in Q3 2022.
  • 54 funds tracked by Wall St. Rank held HilleVax as of Q2 2023.

Based on BVF Inc's 13F filing for Q2 2023, filed 14 Aug 2023.